Watching Arrowhead Pharmaceuticals; Zacks Small-Cap Research Sets $80 Price Valuation; Says This Model Is Highly Dependent Upon The Continued Clinical Success Of Those Programs And Will Be Adjusted Accordingly Based Upon Future Clinical Outcomes
Portfolio Pulse from Happy Mohamed
Zacks Small-Cap Research has set a price valuation of $80 for Arrowhead Pharmaceuticals. The valuation model is highly dependent on the continued clinical success of the company's programs and will be adjusted based on future clinical outcomes.
August 10, 2023 | 4:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Arrowhead Pharmaceuticals' stock price may be influenced by Zacks Small-Cap Research's price valuation of $80. The valuation is dependent on the company's continued clinical success.
The price target set by Zacks Small-Cap Research is a significant indicator of the potential value of Arrowhead Pharmaceuticals. If the company continues to achieve clinical success, the stock price may increase to meet this valuation. However, if the company's clinical programs do not perform as expected, the stock price may be negatively impacted.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100